Adherex to Present at OneMed Forum NY 2011 Conference

RESEARCH TRIANGLE PARK, NC, Jun 20 (MARKET WIRE) --
Adherex Technologies Inc. (TSX-V: AHX) (PINKSHEETS: ADHXF) (the
"Company"), a biopharmaceutical company focused on the development of
eniluracil and 5-fluorouracil, today announced that Robert Andrade, Chief
Financial Officer, will present at the upcoming OneMed Forum NY 2011
Conference on Thursday, June 23 at 10:45 a.m. at the Roosevelt Hotel, 45
East 45th St. New York, NY.

Except for historical information described in this press release, all
other statements are forward-looking. Forward-looking statements are
subject to certain risks and uncertainties inherent in the Company's
business that could cause actual results to vary, including such risks
that regulatory clinical and guideline developments may change,
scientific data may not be sufficient to meet regulatory standards or
receipt of required regulatory clearances or approvals, clinical results
may not be replicated in actual patient settings, protection offered by
the Company's patents and patent applications may be challenged,
invalidated or circumvented by its competitors, the available market for
the Company's products will not be as large as expected, the Company's
products will not be able to penetrate one or more targeted markets,
revenues will not be sufficient to fund further development and clinical
studies, the Company may not meet its future capital needs, and its
ability to obtain additional funding, as well as uncertainties relative
to varying product formulations and a multitude of diverse regulatory and
marketing requirements in different countries and municipalities, and
other risks detailed from time to time in the Company's filings with the
Securities and Exchange Commission including its Annual Report on Form
10-K for the year ended December 31, 2010. Adherex Technologies, Inc.
disclaims any obligation to update these forward-looking statements
except as required by law.

For a more detailed discussion of related risk factors, please refer to
our public filings available at www.sec.gov and www.sedar.com

For further information, please contact:
Rosty Raykov
Chief Executive Officer
Adherex Technologies Inc.
T: (919) 636-5144

Copyright 2011, Market Wire, All rights reserved.

-0-